Clinical Studies Search

Protocol Search Results


Protocol No. Title
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
PSCI-18-004 A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-RiskWNT-Driven Medulloblastoma Patients
PSCI-18-007 Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
PSCI-18-008 Single Arm Phase Ib/II Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer: Big Ten Cancer Research Consortium BTCRC-GU16-043
PSCI-18-014 A Phase Ib/11 Study of Propranolol with fixed-dose Pembrolizumab in Patients with Unresectable Stage III and Stage IV Melanoma
PSCI-18-016 International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
PSCI-18-022 Molecular Genetic, Host-Derived and Clinical Determinants of Long-Term Survival in Glioblastoma
PSCI-18-023 Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
PSCI-18-025 A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
PSCI-18-041 Extracellular Vesicles as Biomarkers for Early Detection of Recurrent Pancreatic Carcinoma
PSCI-18-042 CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts: a prospective, randomized, double-blind, multi-center clinical trial